Sign in

Thomas A. Fitzgerald

Interim Chief Executive Officer at Transcode Therapeutics
Since January 13, 2024
Age
74 years
Education
Holds an A.B. in Economics with Honors from Stanford University and an M.B.A. from the Harvard University Graduate School of Business Administration.
Tenure
Joined RNAZ in 07-2018 as Vice President, Chief Financial Officer, and Director and was promoted to Interim Chief Executive Officer on 01-13-2024.

Also at Transcode Therapeutics

No other executives available

About

Thomas A. Fitzgerald is a seasoned executive with extensive experience in finance and leadership within the life sciences industry. He served in the U.S. Army as an airborne-qualified infantry officer and has built a solid foundation through his military service, which underscores his discipline and leadership qualities.

He holds strong academic credentials, having earned an A.B. in Economics with Honors from Stanford University and an M.B.A. from the Harvard University Graduate School of Business Administration, which have been key contributors to his professional achievements.

During his tenure at RNAZ, he joined in July 2018 as Vice President, Chief Financial Officer, and Director, later transitioning to a full-time role and being promoted to Interim Chief Executive Officer on January 13, 2024. His leadership in these roles has been integral in steering the company's financial and strategic direction.

$RNAZ Performance Under Thomas A. Fitzgerald

Past Roles

OrganizationRoleDate RangeDetails
TransCode Therapeutics, Inc. (RNAZ) Chief Financial Officer N/A Held prior to becoming Interim Chief Executive Officer

Fixed Compensation

Data from  FY 2023
Component NameAmountPayment ScheduleAdditional Details
Salary $382,000 (base salary; adjusted to $358,138 after reduction for three pay periods) N/A [N/A]Voluntary reduction in three pay periods; approximately 3% annual increase observed
Option Awards $68,724 N/A [N/A]Represents the aggregate grant-date fair value calculated under FASB ASC Topic 718; does not reflect actual economic value

Performance Compensation

Data from  FY 2023

No information available on performance compensation for 2023